Clinical Trial Update: A Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With Heart Failure (LAPiS Study) [Phase 1, Phase 2]

View source ↗

Summary

The LAPiS study is a Phase 1/2 clinical trial evaluating iPS cell-derived cardiomyocyte spheroids (HS-001) for heart failure and ischemic heart disease; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Heart Disease

Drugs mentioned

• HS-001

Snippet

Sponsor: Heartseed Inc. | Conditions: Heart Failure, Ischemic Heart Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING